Viking Therapeutics (VKTX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts VKTX Hot Sheet
Join SI Premium – FREE
Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts TIME dotCom Berhad (TDC:MK) at Overweight
- Goldman Sachs Reiterates Buy Rating on NetEase.com (NTES)
- JPMorgan Downgrades Astral Ltd (ASTRA:IN) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
